Contact Us Menu

Effectiveness and Durability of Brolucizumab Treatment in Real-World Neovascular Age-Related Macular Degeneration (nAMD) Patients in the U.S.: Findings from the American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight)

Author: Mathew MacCumber
November 2022
Back